We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Groin Complications Post Percutaneous Coronary Intervention Using Either Manual Compression or PERCLOSE Device

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00842179
First Posted: February 12, 2009
Last Update Posted: February 12, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Abbott Vascular
Information provided by:
Clinyx, LLC
  Purpose
The objective of this study is to compare groin complication rates in low and high risk patients post percutaneous coronary intervention (PCI) closed by either a 6 French Perclose vascular closure device (VCD) or manual compression.

Condition
Vascular Closure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Femoral Access Site Groin Complication Rates After 2517 Groin Punctures Undergoing Vascular Closure by Either Manual Compression or the Perclose Vascular Closure Device

Further study details as provided by Clinyx, LLC:

Primary Outcome Measures:
  • major vascular complications [ Time Frame: 0-30 days (during Index hospitalization) ]

Secondary Outcome Measures:
  • Minor vascular complications [ Time Frame: 0-30 days (during index hospitalization) ]

Enrollment: 2517
Study Start Date: June 2008
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Manual Closure
Patients who received vascular closure with manual compression after percutaneous coronary intervention (PCI)
Perclose Device
Patients who received vascular closure with the Perclose VCD after percutaneous coronary intervention (PCI)

Detailed Description:
It is commonly accepted that that there exists a learning curve in performing successful groin closure with Vascular Closure Devices (VCD). Manual compression continues to be 'standard of care' at most institutions for closure of 5 - 8 French femoral arteriotomies, as previous studies evaluating the safety and efficacy of vascular closure devices have failed to show a statistically significant decrease in groin complication rates when compared to manual compression. Importantly, no studies to date have been performed to specifically assess the potential decrease in vascular complication rates by highly experienced VCD operators, when their safety results are compared to manual compression. This retrospective, multi-center study will demonstrate a lower vascular complication rate in PCI patients post deployment of a 6 Fr Perclose VCD by a single, experienced operator, when compared to manual compression in two comparable, high volume, hospital cardiac catheterization laboratories.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients who require vascular closure post percutaneous coronary intervention
Criteria

Inclusion Criteria:

  • Patients who received vascular closure with the Perclose device post PCI at Baptist Miami Hospital
  • Patients who received vascular closure by manual compression at Tampa General Hospital

Exclusion Criteria:

  • Patients less than 18 years old
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00842179


Locations
United States, Florida
Baptist Hospital of Miami
Miami, Florida, United States, 33176
Sponsors and Collaborators
Clinyx, LLC
Abbott Vascular
Investigators
Principal Investigator: Jonathan Roberts, MD Baptist Health South Florida
  More Information

Responsible Party: Holly Taylor, Clinyx
ClinicalTrials.gov Identifier: NCT00842179     History of Changes
Other Study ID Numbers: CL-003
First Submitted: February 6, 2009
First Posted: February 12, 2009
Last Update Posted: February 12, 2009
Last Verified: February 2009

Keywords provided by Clinyx, LLC:
Perclose


To Top